Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor

Lignende værker

• Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study
  af: Zhuang, Hongqing, et al.
  Udgivet: (2020)
• Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
  af: Brindel, Aurélien, et al.
  Udgivet: (2020)
• EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
  af: Chen, Zhi-Yong, et al.
  Udgivet: (2012)
• Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
  af: Kim, Eun Young, et al.
  Udgivet: (2018)
• Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
  af: Sandblom, Viktor, et al.
  Udgivet: (2020)